Author:
van Waterschoot RAB,ter Heine R,Wagenaar E,van der Kruijssen CMM,Rooswinkel RW,Huitema ADR,Beijnen JH,Schinkel AH
Reference50 articles.
1. Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor;Agarwal;Int J Pharm,2007
2. Guide to Receptors and Channels (GRAC), 4th edn;Alexander;Br J Pharmacol,2009
3. The drug efflux-metabolism alliance: biochemical aspects;Benet;Adv Drug Deliv Rev,2001
4. Increased dose of lopinavir/ritonavir compensates for efavirenz-induced drug-drug interaction in HIV-1-infected children;Bergshoeff;J Acquir Immune Defic Syndr,2005
5. Assessment of the effect of nevirapine on the pharmacokinetics of lopinavir/ritonavir (Kaletra) after multiple dosing in HIV-infected adults;Bertz;Int Conf AIDS,2002
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献